These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 9144145)
1. Iloprost in alginate decreases the thrombogenicity of expanded polytetrafluoroethylene. Viscardi PJ; Page EA; Clark HG; Serafin D; Klitzman B J Reconstr Microsurg; 1997 May; 13(4):303-6. PubMed ID: 9144145 [TBL] [Abstract][Full Text] [Related]
2. The effect of interstitial air on the in vitro thrombogenicity of ePTFE vascular grafts. Rashid SN; Clark HG; Vann RD; Gerth WA; Palmos LA; Mikat EM J Bioact Compat Polym; 1992 Jan; 7(1):54-64. PubMed ID: 11539826 [TBL] [Abstract][Full Text] [Related]
3. Patency of a small vessel prosthesis bonded to tissue plasminogen activator and iloprost. Greco RS; Kim HC; Donetz AP; Harvey RA Ann Vasc Surg; 1995 Mar; 9(2):140-5. PubMed ID: 7540408 [TBL] [Abstract][Full Text] [Related]
4. Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts. Heyligers JM; Verhagen HJ; Rotmans JI; Weeterings C; de Groot PG; Moll FL; Lisman T J Vasc Surg; 2006 Mar; 43(3):587-91. PubMed ID: 16520178 [TBL] [Abstract][Full Text] [Related]
5. Quantification of gas denucleation and thrombogenicity of vascular grafts. Bensen CV; Vann RD; Koger KE; Klitzman B J Biomed Mater Res; 1991 Mar; 25(3):373-86. PubMed ID: 2026642 [TBL] [Abstract][Full Text] [Related]
6. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts. Laredo J; Xue L; Husak VA; Ellinger J; Singh G; Zamora PO; Greisler HP J Vasc Surg; 2004 May; 39(5):1059-65. PubMed ID: 15111862 [TBL] [Abstract][Full Text] [Related]
7. Hydrostatic pressure reduces thrombogenicity of polytetrafluoroethylene vascular grafts. Ritter EF; Vann RD; Wyble C; Barwick WJ; Klitzman B Am J Physiol; 1989 Oct; 257(4 Pt 2):H1076-81. PubMed ID: 2801970 [TBL] [Abstract][Full Text] [Related]
9. Assessments of thrombogenicity by three in vitro techniques. Student Research Award in the Undergraduate, Master Candidate, or Health Science Degree Candidate Category, 21st annual meeting of the Society for Biomaterials, San Francisco, CA, March 18-22, 1995. Skarada DJ; Erickson GR; Warnecke KL; du Laney TV; Greenberg CS; Ritter EF; Klitzman B J Biomed Mater Res; 1995 Sep; 29(9):1039-45. PubMed ID: 8567701 [TBL] [Abstract][Full Text] [Related]
10. Effect of dextran and enoxaparin on early ePTFE graft thrombogenicity in sheep. Matthiasson SE; Bergqvist D; Lundell A; Lindblad B Eur J Vasc Endovasc Surg; 1995 Apr; 9(3):284-92. PubMed ID: 7542544 [TBL] [Abstract][Full Text] [Related]
11. Thrombogenicity of heparin and non-heparin bound arterial prostheses: an in vitro evaluation. Mohamed MS; Mukherjee M; Kakkar VV J R Coll Surg Edinb; 1998 Jun; 43(3):155-7. PubMed ID: 9654873 [TBL] [Abstract][Full Text] [Related]
12. Thrombogenicity of a new injectable biocompatible elastomer for aneurysm exclusion, compared to expanded polytetrafluoroethylene in a human ex vivo model. van der Steenhoven TJ; Bosman WM; Tersteeg C; Jacobs MJ; Moll FL; de Groot PG; Heyligers JM Eur J Vasc Endovasc Surg; 2012 Jun; 43(6):675-80. PubMed ID: 22436262 [TBL] [Abstract][Full Text] [Related]
13. Heparinization of polytetrafluoroethylene (ePTFE) grafts. The effect on pseudointimal hyperplasia. Bergqvist D; Jensen N; Persson NH Int Angiol; 1988; 7(1):65-70. PubMed ID: 3385270 [TBL] [Abstract][Full Text] [Related]
15. The best alternative to reduce thrombogenicity of small diameter grafts. Swedenborg J Acta Chir Scand Suppl; 1990; 555():45-8. PubMed ID: 2195830 [No Abstract] [Full Text] [Related]
16. Prevention of neointimal hyperplasia associated with modified stretch expanded polytetrafluoroethylene hemodialysis grafts (Gore) in an experimental preclinical study in swine. Gessaroli M; Bombardi C; Giunti M; Bacci ML J Vasc Surg; 2012 Jan; 55(1):192-202. PubMed ID: 21944911 [TBL] [Abstract][Full Text] [Related]
17. Development and characterization of an alginate-impregnated polyester vascular graft. Lee JH; Kim WG; Kim SS; Lee JH; Lee HB J Biomed Mater Res; 1997 Aug; 36(2):200-8. PubMed ID: 9261681 [TBL] [Abstract][Full Text] [Related]
18. The effect of low molecular weight dextran on early platelet deposition onto vascular grafts. Al-Huneidi W; Owunwanne A; Christenson JT Int Angiol; 1988; 7(3):266-9. PubMed ID: 2462000 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Effect of Crosslinking Method of Poly(Vinyl Alcohol) Hydrogels on Thrombogenicity. Bates NM; Puy C; Jurney PL; McCarty OJT; Hinds MT Cardiovasc Eng Technol; 2020 Aug; 11(4):448-455. PubMed ID: 32607901 [TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass. Lumsden AB; Morrissey NJ; J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]